Safety of Bevacizumab in Treating Metastatic Colorectal Cancer: A Systematic Review and Meta-analysis of All Randomized Clinical Trials Fei DaiLixing ShuShen Gao Systematic Review 27 August 2013 Pages: 779 - 788
Pharmaceutical Costs of Assisted Reproduction in Spain Maria-Reyes LorenteJuana HernándezFernando Antoñanzas Original Research Article 23 August 2013 Pages: 789 - 794
Pharmacokinetics and Safety of Golimumab in Healthy Chinese Subjects Following a Single Subcutaneous Administration in a Randomized Phase I Trial Yanli ZhuangSally LynHonghui Zhou Original Research Article 24 August 2013 Pages: 795 - 800
Bioequivalence of Canakinumab Liquid Pre-Filled Syringe and Reconstituted Lyophilized Formulations Following 150 mg Subcutaneous Administration: A Randomized Study In Healthy Subjects Andrea ChioatoEmanuele NosedaAlbert J. Dietz Original Research Article 13 September 2013 Pages: 801 - 808
Pharmacokinetics, Safety, and Tolerability of Saroglitazar (ZYH1), a Predominantly PPARα Agonist with Moderate PPARγ Agonist Activity in Healthy Human Subjects Rajendra H. JaniKevinkumar KansagraHarilal Patel Original Research Article Open access 24 September 2013 Pages: 809 - 816
Relationship Between Absolute Neutrophil Count Profiles and Pharmacokinetics of DA-3031, a Pegylated Granulocyte Colony-Stimulating Factor (Pegylated-G-CSF): A Dose Block-Randomized, Double-Blind, Dose-Escalation Study in Healthy Subjects Li Young AhnKwang-Hee ShinKyung-Sang Yu Original Research Article 28 September 2013 Pages: 817 - 824
Adding Pregabalin or Gabapentin for the Management of Community-Treated Patients with Painful Diabetic Peripheral Neuropathy: A Comparative Cost Analysis Antoni SicrasJavier RejasAlbert Planas Original Research Article 02 October 2013 Pages: 825 - 835
The Effect of Active Vitamin D Administration on Muscle Mass in Hemodialysis Patients Atsushi MoriTomoya NishinoShigeru Kohno Original Research Article 26 September 2013 Pages: 837 - 846
A Head-to-Head Comparison of Periprocedural Coagulability Under Anticoagulation with Rivaroxaban Versus Dabigatran in Patients Undergoing Ablation of Atrial Fibrillation Akinori SairakuYukihiko YoshidaYasuki Kihara Original Research Article 01 October 2013 Pages: 847 - 853
Factors Associated with the Length of Remission of Psoriasis Vulgaris Susana CoimbraHugo OliveiraAlice Santos-Silva Short Communication 27 August 2013 Pages: 855 - 860
Erratum to: Safety and Tolerability of Levomilnacipran ER in Major Depressive Disorder: Results from an Open-Label, 48-Week Extension Study Rajnish MagoGiovanna ForeroChangzheng Chen Erratum 12 October 2013 Pages: 861 - 861